BECOME A MEMBER
LOGIN
DONATE
ABOUT US
What is UKONS?
Board Members
MEMBERS INTEREST GROUPS
Acute Oncology Services MIG
Haemato-oncology MIG
Lead Cancer Nurse MIG
Living With and Beyond Cancer MIG
Radiotherapy MIG
Research MIG
Systemic Anticancer Therapy MIG
Young and Early Career Cancer Nurses MIG
GET INVOLVED
Individual Membership
UKONS Champions
UKONS Corporate Partnerships
UKONS forum
UKONS YC/ECN
NEWS AND EVENTS
Latest News
Events
Jobs & Vacancies
Grants & Scholarships
UKONS Conference 2023
News Archive
FAQs
RESOURCES
Non member access
Publicly available resources
Sexual Health and Well-Being in Cancer
CONTACT
HOME
ABOUT US
What is UKONS?
Board Members
MEMBERS INTEREST GROUPS
Acute Oncology Services MIG
Haemato-oncology MIG
Lead Cancer Nurse MIG
Living With and Beyond Cancer MIG
Radiotherapy MIG
Research MIG
Systemic Anticancer Therapy MIG
Young and Early Career Cancer Nurses MIG
GET INVOLVED
Individual Membership
UKONS Champions
UKONS Corporate Partnerships
UKONS forum
UKONS YC/ECN
NEWS AND EVENTS
Latest News
Events
Jobs & Vacancies
Grants & Scholarships
UKONS Conference 2023
News Archive
FAQs
RESOURCES
CONTACT
BECOME A MEMBER
LOGIN
NICE guidance updates
Ovarian cancer: recognition and initial management [CG122]
, (Published 27th April), updated guidance click here to access:
https://www.nice.org.uk/guidance/cg122
Lenalidomide with rituximab for previously treated follicular lymphoma
Technology appraisal guidance [TA627]Published date: 07 April 2020:
https://www.nice.org.uk/guidance/ta627